...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: from IR "Hepalink does not own Zenith shares."
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Fuzzy - in addition to the IR reply on SH not owning Zenith shares, I believe SH's first share purchase was in 2014 along with EC for about $50 million. The spin-out was 2013. Then in 2017, SH made the big plunge with $68 million to pay off the Citi loan. They weren't an RVX shareholder in 2013.

3 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply